205 related articles for article (PubMed ID: 22205746)
41. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.
Shirakawa K; Takaori-Kondo A; Yokoyama M; Izumi T; Matsui M; Io K; Sato T; Sato H; Uchiyama T
Nat Struct Mol Biol; 2008 Nov; 15(11):1184-91. PubMed ID: 18836454
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Stopak K; de Noronha C; Yonemoto W; Greene WC
Mol Cell; 2003 Sep; 12(3):591-601. PubMed ID: 14527406
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
Zhou X; Evans SL; Han X; Liu Y; Yu XF
PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the replication and persistence of simian-human immunodeficiency viruses expressing Vif proteins with mutation of the SLQYLA or HCCH domains in macaques.
Schmitt K; Hill MS; Liu Z; Ruiz A; Culley N; Pinson DM; Stephens EB
Virology; 2010 Sep; 404(2):187-203. PubMed ID: 20627348
[TBL] [Abstract][Full Text] [Related]
46. Advances in the structural understanding of Vif proteins.
Barraud P; Paillart JC; Marquet R; Tisné C
Curr HIV Res; 2008 Mar; 6(2):91-9. PubMed ID: 18336256
[TBL] [Abstract][Full Text] [Related]
47. Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.
Desimmie BA; Smith JL; Matsuo H; Hu WS; Pathak VK
Retrovirology; 2017 Mar; 14(1):19. PubMed ID: 28302150
[TBL] [Abstract][Full Text] [Related]
48. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
Gai Y; Duan S; Wang S; Liu K; Yu X; Yang C; Li G; Zhou Y; Yu B; Wu J; Wang C; Yu X
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675833
[TBL] [Abstract][Full Text] [Related]
49. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
Yu Q; Chen D; König R; Mariani R; Unutmaz D; Landau NR
J Biol Chem; 2004 Dec; 279(51):53379-86. PubMed ID: 15466872
[TBL] [Abstract][Full Text] [Related]
50. Interaction between HIV-1 and APOBEC3 sub-family of proteins.
Arriaga ME; Carr J; Li P; Wang B; Saksena NK
Curr HIV Res; 2006 Oct; 4(4):401-9. PubMed ID: 17073615
[TBL] [Abstract][Full Text] [Related]
51. Vif determines the requirement for CBF-β in APOBEC3 degradation.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Ren F; Tanaka H; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Gen Virol; 2015 Apr; 96(Pt 4):887-892. PubMed ID: 25516542
[TBL] [Abstract][Full Text] [Related]
52. Structural Basis for a Species-Specific Determinant of an SIV Vif Protein toward Hominid APOBEC3G Antagonism.
Binning JM; Chesarino NM; Emerman M; Gross JD
Cell Host Microbe; 2019 Dec; 26(6):739-747.e4. PubMed ID: 31830442
[TBL] [Abstract][Full Text] [Related]
53. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z; Yu Z; Wang L; Zheng Y; Yao X
PLoS One; 2008 Apr; 3(4):e1995. PubMed ID: 18414671
[TBL] [Abstract][Full Text] [Related]
54. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.
Dang Y; Wang X; Zhou T; York IA; Zheng YH
J Virol; 2009 Sep; 83(17):8544-52. PubMed ID: 19535447
[TBL] [Abstract][Full Text] [Related]
55. Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
Gu Q; Zhang Z; Cano Ortiz L; Franco AC; Häussinger D; Münk C
J Virol; 2016 Dec; 90(23):10545-10557. PubMed ID: 27630243
[TBL] [Abstract][Full Text] [Related]
56. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
57. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Davis RW; York IA; Zheng YH
J Virol; 2010 Jun; 84(11):5741-50. PubMed ID: 20335268
[TBL] [Abstract][Full Text] [Related]
58. A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans.
Nakano Y; Yamamoto K; Ueda MT; Soper A; Konno Y; Kimura I; Uriu K; Kumata R; Aso H; Misawa N; Nagaoka S; Shimizu S; Mitsumune K; Kosugi Y; Juarez-Fernandez G; Ito J; Nakagawa S; Ikeda T; Koyanagi Y; Harris RS; Sato K
PLoS Pathog; 2020 Sep; 16(9):e1008812. PubMed ID: 32913367
[TBL] [Abstract][Full Text] [Related]
59. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
[TBL] [Abstract][Full Text] [Related]
60. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
